COUPANG INC (CPNG)
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-11-04
NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-11-04
Research Workspace
Put CPNG beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is slowing — up about 7% over the past year and decelerating.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 36%, softest on returns on capital.
View QualityManagement screens weak on capital allocation, margins, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 57% growth a year, above the roughly 16% analysts expect, leaving little room for error.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 57% in its worst 12-month stretch.
View RiskCoupang's commerce growth has to keep compounding to justify the price. Revenue grew 7% year over year in the latest quarter. The company beat its earnings estimate by 21.7%. It trades at 0.8x sales, matching the peer median. The market is pricing in more growth than we forecast. The company posted a 642.3 billion won operating loss. Peer multiples imply a price about 57% below where it trades. Our read remains intact, though this read is provisional.
Trailing returns as of 2026-11-04. CPNG is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering CPNG (as of Nov 2026).
Based on 5 Wall Street analysts offering 12-month price targets for CPNG in the last 4 months.
Continue this research
Compare CPNG with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CPNG Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 4 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Broadline Retail — fair value, gap to price, and forward P/E.
Compare the value case
Put CPNG next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Grow Product Commerce segment revenue and customer base
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $17.05
The last 12 months of price, then the range of analyst 12-month targets from today’s $17.05.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Official guidance confirms revenue growth and margin expansion targets.

Threatens: Improve overall profitability and reduce operating losses
Large quarterly loss contradicts profitability improvement objective.

Threatens: Improve overall profitability and reduce operating losses
Continued losses challenge profitability improvement goal.

Advances: Grow Product Commerce segment revenue and customer base
Revenue beat supports growth objective despite losses.

Threatens: Grow Product Commerce segment revenue and customer base
Regulatory risks weigh on growth potential.

Threatens: Grow Product Commerce segment revenue and customer base
Softer Q2 guidance raises concerns about growth.

Threatens: Improve overall profitability and reduce operating losses
FTC investigation could impact profitability and operations.

Legal issues could hinder growth and profitability objectives.
